David Blum Selected Research

Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)

9/2009	A randomized, controlled, dose-ranging study investigating single doses of GW406381, naproxen sodium, or placebo in patients with acute pain after third molar tooth extraction.
6/2009	A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
6/2008	Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Blum Research Topics

Disease

37	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 07/2006
29	Seizures (Absence Seizure) 12/2022 - 10/2001
22	Tauopathies 11/2023 - 08/2010
21	Neoplasms (Cancer) 03/2024 - 01/2010
20	Huntington Disease (Huntington's Disease) 06/2018 - 08/2002
19	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 06/2003
11	Parkinson Disease (Parkinson's Disease) 01/2023 - 06/2003
11	Cognitive Dysfunction 01/2021 - 08/2010
10	Pain (Aches) 11/2021 - 03/2007
8	Epilepsy (Aura) 10/2022 - 10/2001
6	Death (Near-Death Experience) 03/2024 - 01/2021
6	Memory Disorders (Memory Loss) 01/2022 - 06/2012
6	Body Weight (Weight, Body) 01/2021 - 01/2013
5	Inflammation (Inflammations) 06/2022 - 02/2005
5	Dementia (Dementias) 11/2021 - 08/2010
5	Dizziness (Lightheadedness) 01/2020 - 08/2006
4	Cachexia 01/2023 - 03/2010
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 11/2021
4	Neuroinflammatory Diseases 11/2021 - 01/2018
4	Gliosis 01/2021 - 04/2007
4	Amyloid Plaque 11/2018 - 05/2012
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 09/2023 - 11/2019
3	Neuralgia (Stump Neuralgia) 11/2022 - 10/2007
3	Delirium 01/2021 - 01/2020
3	Nervous System Diseases (Neurological Disorders) 01/2019 - 06/2003
3	Headache (Headaches) 11/2018 - 03/2007
2	Frontotemporal Dementia (Semantic Dementia) 09/2023 - 07/2010
2	Brain Diseases (Brain Disorder) 01/2023 - 02/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2022 - 10/2007
2	Stroke (Strokes) 06/2022 - 06/2003
2	Myotonic Dystrophy (Dystrophia Myotonica) 01/2022 - 01/2019
2	Sleepiness 01/2020 - 01/2016
2	Nausea 01/2020 - 01/2018
2	Hypothyroidism 01/2019 - 11/2014
2	Hyponatremia 01/2019 - 01/2018
2	Insulin Resistance 01/2019 - 01/2018
2	Atrophy 01/2019 - 01/2007
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018 - 01/2015
2	Multiple Sclerosis 08/2012 - 10/2007
2	Hypothermia 04/2012 - 11/2011
2	Postherpetic Neuralgia 06/2009 - 10/2007
2	Osteoarthritis 06/2008 - 01/2008

Drug/Important Bio-Agent (IBA)

22	eslicarbazepine acetateIBA 12/2022 - 02/2015
17	Amyloid (Amyloid Fibrils)IBA 11/2023 - 06/2012
14	tau Proteins (tau Protein)IBA 01/2022 - 07/2010
13	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 08/2006
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2011
8	Peptides (Polypeptides)IBA 11/2021 - 01/2010
7	Caffeine (No Doz)FDA LinkGeneric 03/2024 - 10/2013
7	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023 - 04/2007
6	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2013
6	Lamotrigine (Lamictal)FDA LinkGeneric 11/2018 - 02/2005
6	3-nitropropionic acidIBA 12/2007 - 10/2002
5	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2015
4	Apomorphine FDA Link 01/2022 - 01/2020
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2015 - 05/2007
3	ChemokinesIBA 09/2023 - 01/2015
3	Nerve Growth Factors (Neurotrophins)IBA 01/2023 - 11/2007
3	CytokinesIBA 01/2023 - 11/2014
3	Amyloid beta-PeptidesIBA 11/2019 - 04/2014
3	Hormones (Hormone)IBA 01/2019 - 01/2018
3	Insulin (Novolin)FDA Link 01/2019 - 01/2018
3	Carbamazepine (Tegretol)FDA LinkGeneric 11/2018 - 08/2006
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2018 - 06/2003
3	N-Methylaspartate (NMDA)IBA 05/2013 - 06/2005
3	GW406381XIBA 09/2009 - 01/2008
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2009 - 06/2008
3	Gabapentin (Neurontin)FDA LinkGeneric 07/2009 - 08/2006
3	Minocycline (Cyclops)FDA LinkGeneric 01/2007 - 12/2004
2	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 11/2022
2	Glutamic Acid (Glutamate)FDA Link 09/2023 - 04/2007
2	InflammasomesIBA 01/2023 - 11/2019
2	Psychotropic Drugs (Psychoactive Drugs)IBA 12/2022 - 01/2019
2	Neuroprotective AgentsIBA 06/2022 - 12/2007
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 01/2018
2	GhrelinIBA 01/2021 - 11/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 01/2018
2	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 05/2013
2	SodiumIBA 01/2019 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2019 - 08/2010
2	Huntingtin ProteinIBA 06/2018 - 01/2008
2	EnzymesIBA 01/2018 - 04/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2017
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2017 - 04/2016
2	Messenger RNA (mRNA)IBA 04/2016 - 01/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2013 - 06/2008
2	polyglutamineIBA 01/2011 - 01/2008
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 07/2009 - 10/2007
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2007 - 12/2004
1	Carboplatin (JM8)FDA LinkGeneric 03/2024

Therapy/Procedure

15	Palliative Care (Palliative Therapy) 01/2024 - 03/2010
15	Therapeutics 07/2023 - 06/2003
4	Radiotherapy 11/2022 - 09/2021
3	Hospice Care (Care, Bereavement) 03/2024 - 01/2024
3	Drug Therapy (Chemotherapy) 03/2024 - 09/2012
3	Transjugular Intrahepatic Portasystemic Shunt 01/2023 - 11/2020
2	Terminal Care (Care, Terminal) 03/2024 - 01/2021
2	Biological Therapy 12/2021 - 11/2021
2	Institutionalization (Institutionalized Persons) 01/2021 - 01/2020